Delivery Order SPE2DB24D9144-SPE2DB24FCMDW
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $59,144.16, is for the delivery of Entyvio 300 mg vials to support the recurring medical supply needs of military health facilities. The delivery order is issued under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $29,572.08 and has an ultimate completion date of October 9, 2024. The contract covers the delivery of Entyvio 300 mg vials, a specialty pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $19,714.72, is for the delivery of Entyvio 300 mg vials to support the recurring medical supply needs of military health facilities. The contract is a task order under a larger indefinite delivery contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $56,709.48, is for the delivery of Entyvio 300 mg vials, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order, valued at $19,714.72, is for the supply of Entyvio 300 mg vials. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows the DLA to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,834.79 contract is for the supply of Entyvio 300 mg vials, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $39,429.44 and is for the delivery of Entyvio 300 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, with a potential value of up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $59,144.16, is for the delivery of 300 mg vials of Entyvio, a prescription biologic medication. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue firm...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,643.40, is for the delivery of Entyvio 300 mg vials to support the recurring medical supply needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,449.30 contract is for the delivery of Entyvio 300 mg vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB24FCMDWDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,572.08, is for the delivery of Entyvio 300 mg vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) vehicle awarded to DMS Pharmaceutical Group by the DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items. The IDC, under the SPE2DB program, runs through December 31, 2025 and complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.6k | 5/13/24 |